Table 3.
SNP | Model | Asian | Caucasian | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P | I2 (%) | OR | 95% CI | P | I2 (%) | ||
ApaI | T versus G | 0.96 | 0.85–1.09 | 0.53 | 55 | 1.15 | 0.90–1.47 | 0.25 | 0 |
TT versus GG | 0.82 | 0.62–1.09 | 0.17 | 0 | 1.35 | 0.82–2.21 | 0.24 | 5 | |
TG versus GG | 1.07 | 0.89–1.30 | 0.46 | 66 | 1.21 | 0.76–1.91 | 0.42 | 7 | |
TT + TG versus GG | 1.02 | 0.85–1.23 | 0.81 | 67 | 1.26 | 0.82–1.93 | 0.30 | 0 | |
TT versus TG + GG | 0.82 | 0.63–1.05 | 0.11 | 0 | 1.17 | 0.81–1.70 | 0.40 | 0 | |
BsmI | A versus G | 0.88 | 0.62–1.25 | 0.47 | 69 | 0.97 | 0.76–1.24 | 0.26 | 0 |
AA versus GG | 1.89 | 0.55–6.46 | 0.31 | 0 | 1.00 | 0.61–1.65 | 1.00 | 0 | |
AG versus GG | 0.74 | 0.50–1.11 | 0.14 | 76 | 0.82 | 0.55–1.20 | 0.30 | 0 | |
AA + AG versus GG | 0.80 | 0.55–1.18 | 0.26 | 75 | 0.86 | 0.60–1.24 | 0.42 | 0 | |
AA versus AG + GG | 2.03 | 0.59–6.98 | 0.26 | 0 | 1.12 | 0.72–1.73 | 0.62 | 0 | |
FokI | C versus T | 1.34 | 1.04–1.72 | – | – | 1.61 | 1.09–2.40 | – | – |
CC versus TT | 2.23 | 1.26–3.95 | – | – | 3.00 | 1.27–7.08 | – | – | |
CT versus TT | 2.10 | 1.19–3.69 | – | – | 2.50 | 1.06–5.64 | – | – | |
CC + CT versus TT | 2.16 | 1.26–3.70 | – | – | 2.68 | 1.21–5.90 | – | – | |
CC versus CT + TT | 1.24 | 0.88–1.75 | – | – | 1.53 | 0.87–2.69 | – | – | |
TaqI | C versus T | 0.98 | 0.71–1.35 | 0.90 | 0 | 1.06 | 0.83–1.36 | 0.64 | 7 |
CC versus TT | – | – | – | 0 | 1.16 | 0.70–1.93 | 0.57 | 0 | |
CT versus TT | 0.98 | 0.71–1.36 | 0.90 | 0 | 0.99 | 0.77–1.26 | 0.89 | 55 | |
CC + CT versus TT | 0.98 | 0.71–1.36 | 0.90 | 0 | 1.03 | 0.72–1.46 | 0.88 | 51 | |
CC versus CT + TT | – | – | – | 0 | 1.18 | 0.74–1.88 | 0.50 | 0 |
OR: Odds ratio; CI: Confidence interval; VDR: Vitamin D receptor; PD: Parkinson’s disease; SNP: Single nucleotide polymorphism.